About ANYA BIOPHARM
ANYA BIOPHARM is a publicly listed company based in Taipei (Taiwan) founded in 2016. Business development, market expansion, and regulatory affairs services are provided. The company has 12 employees. Its Indian entity Anya Biopharm India Llp reported revenue of ₹3.10 Cr. Its focus areas include Biopharma Outsourcing, Consulting and Diversified.
Company details
ANYA BIOPHARM was established in 2016 and is based in Taipei, Taiwan. Services in business development, market expansion, and regulatory affairs are offered to biopharmaceutical companies. Support is provided for strategic planning, entry into international markets, and compliance with industry regulations. Operations are centered on advisory roles to aid growth and operational challenges in the sector. The companys domain, anyabiopharm.com, serves as the primary online resource for inquiries.
- Headquarters Taipei, Taiwan
- Employees 12
- Stage Public
- SectorsHealthcare
- Website anyabiopharm.com/en
- Social LinkedIn
- Legal Name Anya Biopharm, Inc.
- Indian entity revenue₹3.10 Cr
FY 2026 · -17% YoY
- Indian entity net profit₹14.9 Lakh
FY 2026 · 5% margin
- Indian entity EBITDA₹23 Lakh
FY 2026 · 7% margin
- Employee Count12
Associated legal entities of ANYA BIOPHARM
ANYA BIOPHARM operates through Anya Biopharm India Llp (converted and dissolved). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Anya Biopharm India Llp CIN AAQ-7184 | Converted And Dissolved | 03 Oct 2019 | Ahmedabad, Gujarat | ₹3.1 Cr | 2 | View details |
Board of directors of Anya Biopharm India Llp (ANYA BIOPHARM)
Anya Biopharm India Llp is the primary company behind ANYA BIOPHARM. The board of Anya Biopharm India Llp currently have 2 directors; the longest-serving is Siegfried Gschliesser, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Siegfried Gschliesser DIN 08277752 | Designated Partner | 03 Oct 2019 | 7 yrs 1 mo | Anya Biopharm India Llp |
| Bhushan Dhruvkumar Desai DIN 07948719 | Designated Partner | 03 Oct 2019 | 7 yrs 1 mo | Anya Biopharm India Llp |
IPO & Listings of ANYA BIOPHARM
ANYA BIOPHARM is a publicly listed company on the TPEX with ticker symbol 7776 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date25 Oct 2024
- Listed onTT: 7776
- Listed entityAnya Biopharm, Inc.
- Exchange sectorHealth technology
- ISINTW0007776007
- Share price33.15 TWD (+0.76% on the day) · 2026-10-14
- Market capitalisation1,615,440,008.00 TWD
- EPS (diluted, trailing year)-1.00 TWD
- Volume (last session)58,516
Financials of ANYA BIOPHARM
Figures of Anya Biopharm India Llp, the primary company behind ANYA BIOPHARM, for FY 2026. Revenue was ₹3.10 Cr (-17% year on year). Net profit was ₹14.9 Lakh (5% margin). EBITDA was ₹23 Lakh (7% margin). Revenue has grown at a compounded annual rate of +69% over three years and +54% over five years.
- ₹3.10 CrRevenue · FY 2026 · -17% YoY
- ₹14.9 LakhNet profit · 5% margin
- ₹23 LakhEBITDA · 7% margin
- +69%Revenue CAGR, 3 years
- +54%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Anya Biopharm India Llp are on its company page.
Detailed financial statements for ANYA BIOPHARM
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of ANYA BIOPHARM
The website of ANYA BIOPHARM (anyabiopharm.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 130.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ANYA BIOPHARM
ANYA BIOPHARM was founded in 2016.
ANYA BIOPHARM is headquartered in Taipei, Taiwan.
ANYA BIOPHARM has 12 employees.
The primary company behind ANYA BIOPHARM, Anya Biopharm India Llp, reported revenue of ₹3.10 Cr for FY 2026, down 17% year on year.
ANYA BIOPHARM was established in 2016 and is based in Taipei, Taiwan. Services in business development, market expansion, and regulatory affairs are offered to biopharmaceutical companies. Support is provided for strategic planning, entry into international markets, and compliance with industry regulations. Operations are centered on advisory roles to aid growth and operational challenges in the sector. The companys domain, anyabiopharm.com, serves as the primary online resource for inquiries.
Yes, ANYA BIOPHARM is publicly traded on TPEX under the ticker symbol 7776.
ANYA BIOPHARM operates through Anya Biopharm India Llp.
The legal entities of ANYA BIOPHARM currently have 2 directors, including Siegfried Gschliesser, Bhushan Dhruvkumar Desai.